The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study
Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Propofol is currently the most common drug used but has drawbacks like narrow therapeutic window and potential complications. Dexmedetomidine is an attractive alternative due to its unique properties like minimal respiratory depression. Studies are ongoing to find the optimal use of dexmedetomidine for these procedures. A combination of propofol and dexmedetomidine might be ideal, but the best balance between the two drugs needs further investigation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Patients aged 18-65
• Both sexes
• ASA I-II
• BMI \<35
Locations
Other Locations
Egypt
Theodor Bilharz Research Institute
RECRUITING
Cairo
Contact Information
Primary
Sameh M. Elaidy, Msc.
sameh.elaidy@hotmail.com
1111776906
Backup
Nabawya Kamel, Proffessor
n.kamal21@hotmail.com
1066175989
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2024-10-01
Participants
Target number of participants: 52
Treatments
Experimental: The Dexmedetomidine Group D1
D1 group will receive 1µg.kg as a loading dose over 10 minutes, followed by maintenance 0.5 µg.kg.
Experimental: The Dexmedetomidine Group D 0.5
D 0.5 group will receive 0.5 µg.kg as a loading dose over 10 minutes, followed by maintenance 0.5 µg.kg
Experimental: The Dexmedetomidine Group D0.25
D 0.25 group will receive 0.25 µg.kg as a loading dose over 10 minutes, followed by maintenance 0.5 µg.kg
Placebo_comparator: The Dexmedetomidine Group D 0
D 0 group will receive a placebo saline infusion over 10 minutes and then will receive 50 ml of normal saline as a placebo
Related Therapeutic Areas
Sponsors
Leads: Theodor Bilharz Research Institute